sorafenib accord
accord healthcare s.l.u. - sorafenib tosilate - carcinoma, hepatocellular; carcinoma, renal cell - daganatellenes szerek - hepatocellular carcinomasorafenib accord is indicated for the treatment of hepatocellular carcinoma (see section 5. renal cell carcinomasorafenib accord is indicated for the treatment of patients with advanced renal cell carcinoma who have failed prior interferon-alpha or interleukin-2 based therapy or are considered unsuitable for such therapy.
sorafenib teva 200 mg filmtabletta
teva b.v. - sorafenib -
sorafenib sandoz 200 mg filmtabletta
sandoz hungária kft. - sorafenib tosylate -
sorafenib viatris 200 mg filmtabletta
viatris ltd. - sorafenib -
sorafenib g.l. pharma 200 mg filmtabletta
g.l. pharma gmbh - sorafenib tosylate -
sorafenib pharmascience 200 mg filmtabletta
pharmascience international ltd. - sorafenib -
sorafenib stada 200 mg filmtabletta
stada arzneimittel ag - sorafenib tosylate -
sorafenib onkogen 200 mg filmtabletta
onkogen kft. - sorafenib -
sorafenib sandoz 400 mg filmtabletta
sandoz hungária kft. - sorafenib -
sorafenib stada 400 mg filmtabletta
stada arzneimittel ag - sorafenib -